Noticias y vídeos - GB SCIENCES INC. GBLX - Página 2

GB Sciences Declares A "Research Revolution" At Its "2018 Innovation In Medical Cannabis Therapies" Symposium PR Newswire LAS VEGAS, Dec. 14, 2018 On November 9 th , GB Sciences hosted an open mic-dialogue with key stakeholders in the cannabis industry that focused on addressing medical patients' needs through improved standardization and innovation of future medical cannabis products. LAS VEGAS , Dec. 14, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces the success of its first...

GB Sciences and The Colorado Hemp Project Sell First Hemp Crop for $0.7 Million Dollars Additionally, this first crop provides important seeds and genetics for future crops PR Newswire LAS VEGAS, Dec. 12, 2018 LAS VEGAS , Dec. 12, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that their first crop in the rapidly expanding hemp market expects to yield a gross profit of $0.7million dollars as well as seeds and genetics. These seeds and genetic information will provide the mother...

Dr. Andrea Small-Howard, GB Sciences' Chief Science Officer, Introduces, "Unique Methods to Identify Strong Lead Compounds" at the International Cannabinoid Derived Pharmaceutical Summit Dr. Small-Howard will elucidate GB Sciences' Natural Products-Based Approach to Drug Discovery and is a panelist for the "Welcome Panel Session: Bringing Together Industry and Academia". PR Newswire LAS VEGAS, Dec. 11, 2018 LAS VEGAS , Dec. 11, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announced today...

GB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases PR Newswire LAS VEGAS, Dec. 7, 2018 As a Public Institution of Higher Education, the LSU AgCenter's public/private partnership with GB Sciences represents a first in the therapeutic cannabis industry LAS VEGAS , Dec. 7, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces on November...

GB Sciences Co-Authors a Peer-Reviewed Article Showing that Heart Failure Can Be Mitigated, and Reversed, by Orally Administered Drugs Targeting a Cellular Cannabinoid Receptor PR Newswire LAS VEGAS, Nov. 27, 2018 Pioneering new scientific research in the publication, Channels, explains the promise of targeting the ionotropic cannabinoid receptor TRPV1, for the treatment and reversal of heart failure. LAS VEGAS , Nov. 27, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is pleased to...

GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time-Released, Myrcene-Based Nanoparticles PR Newswire LAS VEGAS, Nov. 20, 2018 First of their kind, myrcene nanoparticles are central to a novel, time-released therapeutic for neuropathic pain LAS VEGAS , Nov. 20, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) and the Universidad de Sevilla (USE) announce the filing of a provisional patent application on the creation of...

More From Meredith Patterson, GB Sciences' Brain Nurse, As She Examines the Workings of CBD Curious about the medical properties of cannabis, Meredith Patterson RN, BSN, CRRN aka "the brain nurse", provides a "tour guide through the lobes" as she writes a series of popular science cannabis blogs for GB Sciences. PR Newswire LAS VEGAS, Nov. 14, 2018 LAS VEGAS , Nov. 14, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) offers a series of blogs by "the brain nurse", Meredith Patterson RN , BSN,...

GB Sciences Expands into the Oklahoma Medical Cannabis Market PR Newswire LAS VEGAS, Nov. 14, 2018 GB Sciences' signs a letter of binding agreement with 4EVERGRN in its first out-of-state licensing deal. LAS VEGAS , Nov. 14, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) is proud to announce that it has signed a binding letter of intent with 4EVERGRN, LLC in Oklahoma. This company has been awarded cultivation, processing and dispensary licenses by the Oklahoma Medical Marijuana Authority....

Meredith Patterson, GB Sciences' Brain Nurse, Examines the Workings of CBD Curious about the medical properties of cannabis, Meredith Patterson RN, BSN, CRRN aka "the brain nurse", provides a "tour guide through the lobes" as she writes a series of popular science cannabis blogs for GB Sciences. PR Newswire LAS VEGAS, Nov. 6, 2018 LAS VEGAS , Nov. 6, 2018 /PR Newswire/-- GB Sciences, Inc. (OTCQB: GBLX) offers a series of blogs by "the brain nurse", Meredith Patterson RN , BSN, CRRN. In her over...

GB Sciences Sponsors "2018 Innovation In Medical Cannabis Therapies" Symposium On November 9th, an international medical cannabis symposium, led by Dr. Andrea Small-Howard, will be held in Las Vegas, NV. PR Newswire LAS VEGAS, Nov. 1, 2018 LAS VEGAS , Nov. 1, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces sponsorship of a one day, November 9th , international medical cannabis symposium, "Innovation in Medical Cannabis Therapies", under the direction of Dr. Andrea Small-Howard ,...

GB Sciences' Brain Nurse Explores the New and Exciting World of Medical Cannabis Curious about the medical properties of cannabis, Meredith Patterson RN, BSN, CRRN aka "the brain nurse", provides a "tour guide through the lobes" as she writes a series of popular science cannabis blogs for GB Sciences. PR Newswire LAS VEGAS, Oct. 25, 2018 LAS VEGAS , Oct. 25, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) introduces "the brain nurse", Meredith Patterson RN , BSN, CRRN. In her over 25yrs of...

GB Sciences Harvests the First Hemp Crop in Colorado Harvesting the first crop, in association with the Colorado Hemp Project, GB Sciences explores hemp as a highly reliable source of hard to find cannabinoids and terpenes for cannabis-based medical formulations as well as a fresh source of revenue from the sale of hemp oil and related products. PR Newswire LAS VEGAS, Oct. 16, 2018 LAS VEGAS , Oct. 16, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces the harvesting of its first...

GB Sciences' CEO John Poss and Chief Science Officer Dr. Andrea Small-Howard Featured at Digital Hollywood's California Cannabis Forum in Los Angeles Mr. Poss will speak on GB Sciences' collaboration with Native Americans in California; Dr. Small-Howard will discuss research to address specific diseases using cannabinoids. PR Newswire LAS VEGAS, Oct. 10, 2018 LAS VEGAS , Oct. 10, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that CEO John Poss and Chief Science Officer Dr....

GB Sciences' Dr. Andrea Small-Howard Presents Results of GB Sciences' Novel Pain Formulation Research at UCLA during CannMed 2018 PR Newswire LAS VEGAS, Oct. 9, 2018 Dr. Small-Howard explains the mechanisms for the treatment of chronic and neuropathic pain using proprietary, cannabis-based formulations LAS VEGAS , Oct. 9, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that their Chief Science Officer, Dr. Andrea Small-Howard ( http://www.cannmedevents.com/andrea-small-howard/ ),...

GB Sciences and University of Athens, Greece, Embark on Next-Level Drug Discovery Examining Cannabis-Based, Disease-Modifying Compounds PR Newswire LAS VEGAS, Oct. 3, 2018 GB Sciences explores the therapeutic potential of the chemical diversity within different varieties of the cannabis plant to make better medicine for patients worldwide. LAS VEGAS , Oct. 3, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) initiates a new project with the Department of Pharmacognosy and Natural Products...

GB Sciences' Drug Development Program Benefits from Establishment of Clear Pathway for Cannabis-Based Drug Approvals and Commercialization PR Newswire LAS VEGAS, Oct. 2, 2018 DEA rescheduling of Epidiolex to Schedule V establishes commercial viability for cannabis-based formulations LAS VEGAS , Oct. 2, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has gained momentum in its innovative drug discovery program with the Drug Enforcement Administration (DEA)'s decision to reschedule GW...

GB Sciences Granted a Recreational Production License for the Manufacture of Oils, Edibles, Vape Products, and Nutraceuticals The new license provides access to the largest growing sectors in the cannabis industry. Multiple new brands for both medical and recreational markets being prepped for retail sales. PR Newswire LAS VEGAS, Sept. 25, 2018 LAS VEGAS , Sept. 25, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) has been granted a recreational production license for the manufacture of...

GB Sciences Hosts Cutting-Edge Cannabis Symposium "Innovation in Medical Cannabis Therapies" PR Newswire LAS VEGAS, Sept. 20, 2018 Nationally recognized researchers from the Medical Cannabis World will discuss the benefits of medical cannabis LAS VEGAS , Sept. 20, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB:GBLX) has mobilized cannabis industry thought leaders to discuss both the immense potential for cannabis-based therapies and the challenges of delivering on their medical promise under...

GB Sciences' Dr. Andrea Small-Howard, Chief Science Officer, Will Be Moderating a Panel Discussion in "Cannabis Is Medicine" at the "State of Cannabis" Conference on the Queen Mary PR Newswire LAS VEGAS, Sept. 18, 2018 Dr. Andrea Small-Howard is featured in the "Meeting of the Minds" at the two-day educational conference hosted on the historic Queen Mary. LAS VEGAS , Sept. 18, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) announces that Dr. Andrea Small-Howard will be moderating the panel...

The State of Louisiana Pharmacy Board Has Selected Nine Initial Pharmacies to Dispense Medical Cannabis Formulations Through the GB Sciences and LSU Agriculture Center Partnership PR Newswire BATON ROUGE, La., Aug. 23, 2018 In Partnership with GB Sciences and LSU AgCenter, Nine Select Louisiana Pharmacies Are Set to Pioneer the Louisiana Medical Cannabis Program. BATON ROUGE, La. , Aug. 23, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB:GBLX) With the first cannabis crop now in production at...